Overview

VisionGate, Inc. is a clinical-stage oncology pharmaceutical and diagnostics company dedicated to saving lives through early cancer detection and prevention. Utilizing its proprietary Cell-CT™ platform, the company offers non-invasive, high-resolution 3D cell imaging for the early detection of lung cancer and bronchial dysplasia.

Therapeutic areas

Lung Cancer DetectionBronchial DysplasiaCancer Diagnostics

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Visiongate, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Visiongate, Inc.? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.